Darwin Global Management, Ltd. Top Holdings and 13F Report (2025) About Darwin Global Management, Ltd.Investment ActivityDarwin Global Management, Ltd. has $2.38 billion in total holdings as of June 30, 2025.Darwin Global Management, Ltd. owns shares of 5 different stocks, but just 1 company or ETF makes up 80% of its holdings.Approximately 19.76% of the portfolio was purchased this quarter.This quarter, Darwin Global Management, Ltd. has purchased 3 new stocks and bought additional shares in 3 stocks.Darwin Global Management, Ltd. sold shares of 0 stocks and completely divested from 0 stocks this quarter.Largest Holdings Insmed $1,924,596,343Verona Pharma PLC American Depositary Share $387,440,761CIDARA THERAPEUTICS INC $37,998,567Merus $20,970,157Allogene Therapeutics $12,366,153 Largest New Holdings this Quarter 171757206 - CIDARA THERAPEUTICS INC $37,998,567 HoldingN5749R100 - Merus $20,970,157 Holding Largest Purchases this Quarter Insmed 3,946,646 shares (about $392.65M)CIDARA THERAPEUTICS INC 768,424 shares (about $38.00M)Merus 395,738 shares (about $20.97M)Verona Pharma PLC American Depositary Share 206,414 shares (about $19.37M)Allogene Therapeutics 30,000 shares (about $35.40K) Sector Allocation Over TimeMap of 500 Largest Holdings ofDarwin Global Management, Ltd. Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorINSMInsmed$1,924,596,343$392,651,810 ▲25.6%19,344,62180.8%MedicalVRNAVerona Pharma PLC American Depositary Share$387,440,761$19,365,761 ▲5.3%4,129,61816.3%MedicalCIDARA THERAPEUTICS INC$37,998,567$37,998,567 ▲New Holding768,4241.6%COM NEWMRUSMerus$20,970,157$20,970,157 ▲New Holding395,7380.9%MedicalALLOAllogene Therapeutics$12,366,153$35,400 ▲0.3%10,479,7910.5%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access